| Literature DB >> 31297715 |
Sami Nikkonen1,2, Juha Töyräs3,4,5, Esa Mervaala4,6, Sami Myllymaa3,4, Philip Terrill5, Timo Leppänen3,4.
Abstract
BACKGROUND: Diagnostics of obstructive sleep apnea (OSA) is based on apnea-hypopnea index (AHI) determined as full-night average of occurred events. We investigate our hypothesis that intra-night variation in the frequency of obstructive events affects diagnostics and prognostics of OSA and should therefore be considered in clinical practice.Entities:
Keywords: AHI; Diagnostics; OSA; Prognostics
Year: 2019 PMID: 31297715 PMCID: PMC7127992 DOI: 10.1007/s11325-019-01885-5
Source DB: PubMed Journal: Sleep Breath ISSN: 1520-9512 Impact factor: 2.816
The patient demographic data: median (range) for continuous parameters and N (% of valid cases) for categorical variables in non-OSA, mild, moderate, and severe obstructive sleep apnea categories. The parameter “missing” represents the number of patients of which the information in question was not available
| Severity classification | Non-OSA | Mild | Moderate | Severe |
|---|---|---|---|---|
| Number of patients | 967 | 505 | 257 | 260 |
| Follow-up time (years) | 19.4 (0.2–26.0) | 19.1 (0.0–26.0)* | 17.8 (1.0–25.7) | 17.8 (0.1–25.9) |
| Age (years) | 45.8 (18.3–69.6)* | 50.3 (25.4–79.9) | 50.2 (27.8–80.3) | 51.6 (20.6–81.1) |
| BMI (kg/m2) | 26.6 (17.5–63.3)* | 28.7 (18.7–60.6)* | 30.7 (19.2–56.1)* | 34.5 (21.1–74.0) |
| Missing ( | 60 | 12 | 2 | 3 |
| AHIstandard (1/h) | 1.5 (0.0–4.9)* | 8.6 (5.0–14.9)* | 20.8 (15.1–29.8)* | 47.6 (30.0–148.7) |
| Male gender | 643 (66.5) | 392 (77.6) | 213 (82.9) | 232 (89.2) |
| Smoking | ||||
| Yes | 274 (31.8) | 136 (28.6) | 60 (25.8) | 79 (32.2) |
| Quit | 198 (23.0) | 128 (26.9) | 74 (31.8) | 84 (34.3) |
| No | 389 (45.2) | 212 (44.5) | 99 (45.2) | 82 (33.5) |
| Missing | 106 | 20 | 24 | 15 |
| CPAP | 48 (5.0)# | 96 (19.0)# | 100 (38.9)# | 148 (57.1) |
| Missing ( | 15 | 1 | 0 | 1 |
The patients were divided into the obstructive sleep apnea categories based on conventional full-night apnea-hypopnea index (AHIstandard). An asterisk (*) and a hashtag (#) denote statistically significant (p < 0.05) difference between the marked category and one level more severe obstructive sleep apnea category. Statistical significances were evaluated using Mann-Whitney U test (*) and chi-square test (#)
Definitions of the parameters used in this study
| Parameter | Description | Definition |
|---|---|---|
| Apnea-hypopnea index (1/h) | The number of apnea and hypopnea events per hour | |
| Oxygen desaturation index (1/h) | The number of desaturation events per hour | |
| Apnea duration (s) | The duration of an apnea event | |
| Hypopnea duration (s) | The duration of a hypopnea event | |
| Desaturation duration (s) | The duration of a desaturation event | |
| Apnea proportion (%) | The proportion of apnea events out of all obstructive events |
napnea events, nhypopnea events, and ndesaturation events denote the number of scored apnea, hypopnea, and desaturation events during the analyzed time. tanalyzed denotes the total analyzed time
Fig. 1Illustration of the moving windows used for AHI2h calculation. The 2-h window was moved from the beginning of the recording in 1 min interval to the end of the recording. AHI2h was calculated for every window, and the window with the highest number of events was selected as the worst 2h
Fig. 2Hourly medians for apnea-hypopnea index (AHI), average apnea duration, average hypopnea duration, oxygen desaturation index (ODI), average desaturation duration, and apnea proportion of all obstructive events. An asterisk (*) denotes a statistically significant (p < 0.05) trend in the median based on linear one-way ANOVA contrasts test
Fig. 3Histogram presenting the start times for the 2-h window with the highest AHI (AHI2h)
Fig. 4Absolute and normalized confusion matrices showing how the patients are classified to each obstructive sleep apnea category when the classification is based on full-night AHI (AHIstandard) and the 2-h window with the highest AHI (AHI2h)
Hazard ratios (95% confidence interval) for all-cause mortality, cardiovascular mortality, and non-cardiovascular mortality in each OSA severity category when the severity classification was based on full-night AHI (AHIstandard), and the 2 h with highest AHIs (AHI2h)
| OSA severity: mild | OSA severity: moderate | OSA severity: severe | Age (increase of 1 year) | BMI (increase of 1 unit) | Male gender | Smoking: yes | Smoking: quit | CPAP | |
|---|---|---|---|---|---|---|---|---|---|
| All-cause mortality | |||||||||
| AHIstandard | 1.13 (0.84–1.51) | 1.76* (1.27–2.44) | 1.75* (1.22–2.51) | 1.09* (1.08–1.10) | 1.04* (1.02–1.05) | 1.55* (1.15–2.08) | 2.37* (1.82–3.09) | 1.13 (0.86–1.49) | 0.73* (0.55–0.96) |
| AHI2h | 1.33 (0.93–1.91) | 1.56* (1.07–2.27) | 1.94* (1.33–2.83) | 1.09* (1.07–1.10) | 1.04* (1.02–1.05) | 1.53* (1.14–2.06) | 2.37* (1.82–3.09) | 1.13 (0.86–1.48) | 0.75* (0.57–0.98) |
| Cardiovascular mortality | |||||||||
| AHIstandard | 0.90 (0.57–1.44) | 1.61 (0.98–2.63) | 1.44 (0.83–2.51) | 1.13* (1.10–1.15) | 1.05* (1.03–1.08) | 2.26* (1.38–3.70) | 3.47* (2.29–5.23) | 1.22 (0.79–1.88) | 0.71 (0.46–1.09) |
| AHI2h | 1.09 (0.62–1.92) | 1.28 (0.71–2.30) | 1.64 (0.92–2.90) | 1.13* (1.11–1.15) | 1.05* (1.03–1.08) | 2.23* (1.36–3.65) | 3.44* (2.28–5.19) | 1.21 (0.79–1.87) | 0.71 (0.47–1.08) |
| Non-cardiovascular mortality | |||||||||
| AHIstandard | 1.28 (0.88–1.87) | 1.99* (1.28–3.11) | 2.32* (1.46–3.70) | 1.08* (1.06–1.10) | 1.02* (1.00–1.05) | 1.26 (0.86–1.82) | 2.02* (1.43–2.84) | 1.09 (0.77–1.54) | 0.66* (0.46–0.96) |
| AHI2h | 1.53 (0.96–2.45) | 1.84* (1.13–3.01) | 2.46* (1.49–4.07) | 1.08* (1.06–1.10) | 1.03* (1.00–1.05) | 1.25 (0.86–1.81) | 2.03* (1.43–2.86) | 1.09 (0.77–1.54) | 0.71 (0.49–1.02) |
Hazard ratios were calculated with Cox proportional hazards model. Statistically significant (p < 0.05) hazard ratios are denoted with an asterisk (*)
Fig. 5Kaplan-Meier survival curves for each obstructive sleep apnea category when the classification is based on full-night AHI (AHIstandard) and the 2-h window with the highest AHI (AHI2h)